Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNo — taking two 2.5mg Mounjaro shots is not recommended and goes against the licensed dosing schedule. Each Mounjaro KwikPen delivers one weekly injection at whatever strength your prescriber has set; doubling up on 2.5mg does not accelerate results and raises your risk of side effects. Mounjaro is a prescription-only medicine, and any change to your dose or schedule needs to be agreed with your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is a question our prescribers hear most weeks, and it's an understandable one. The 2.5mg dose can feel almost imperceptible at first. Appetite suppression may be subtle, the scale may barely move, and it's tempting to wonder whether a second injection would tip the balance. But the reasoning behind that first four weeks on 2.5mg isn't about weight loss at all.
Tirzepatide, the active ingredient in Mounjaro, works by activating both the GIP and GLP-1 receptors involved in appetite regulation and gastric emptying. That dual action is potent. The licensed schedule (verified in detail on the Mounjaro overview page) begins at 2.5mg precisely because starting higher causes more nausea, vomiting and digestive discomfort for most people. The starter dose is there so your body can adjust, not so you can lose weight in week one. That's a subtle but important distinction.
Taking a second 2.5mg injection in the same week doesn't replicate the next dose up. It exposes you to double the weekly dose of a medicine that already slows gastric emptying significantly, and does so outside any clinical monitoring. The NHS tirzepatide patient information page is clear that Mounjaro is used as a once-weekly injection, and the SmPC (the formal prescribing document) specifies one injection per week at the current prescribed strength.
If you feel your current dose isn't working, that's exactly the kind of signal your prescriber needs to hear, not a prompt to self-adjust. If you're still unsure whether taking two doses of 2.5mg Mounjaro could ever be appropriate, our dedicated page works through the clinical reasoning in full.
Two 2.5mg injections in a week effectively deliver 5mg of tirzepatide, but without the gradual titration that makes 5mg tolerable for most patients. The difference matters. When prescribers move patients from 2.5mg to 5mg, they do so after four weeks of acclimatisation. That window allows the gut to adapt to slowed gastric motility, and allows the prescriber to check that no contraindications have emerged.
Bypassing that step by doubling up raises the likelihood of nausea, vomiting and diarrhoea landing harder and faster than they would during a properly paced dose increase. Dehydration from persistent vomiting is a genuine concern with GLP-1 medicines, the MHRA's safety communications on this medicine class flag it as a reason to seek urgent medical advice if severe symptoms develop. There's also no clinical evidence that front-loading exposure speeds up weight loss over the medium term; the trial data on which Mounjaro's licence rests used the standard titration schedule throughout.
People sometimes ask the related question of whether taking two shots of 2.5mg Mounjaro might be safer than jumping straight to 5mg. The answer is still no, the pharmacology doesn't work that way, and it leaves you without a prescriber's oversight at a point where side effects are most likely to appear.
For a closer look at how the 5mg pen differs and what to expect when titration is done properly, the Mounjaro 5mg page covers that transition in detail.
There's a right way to raise your dose, and it doesn't involve a second pen. Contact your prescriber and explain what you're noticing, or not noticing. A clinical review before titration isn't a formality; it's the moment your prescriber checks your weight, any side effects you've had, and whether there are reasons to wait or move forward. Some people tolerate 2.5mg very well and progress to 5mg on schedule. Others need an extra week or two. Both are normal.
If you're experiencing the opposite problem (side effects that feel difficult on 2.5mg) the Mounjaro 5mg nausea page has practical guidance on managing GI symptoms through titration, much of which applies at the starter dose too. And if you're weighing up the overall cost picture alongside your dose journey, our Mounjaro price comparison guide explains what a legitimate private prescription should include beyond the pen itself.
The broader weight-loss treatment overview is worth reading if you're still early in your Mounjaro journey and want to understand where the medicine fits alongside diet and activity changes. Dose increases are a clinical milestone, not a workaround, and getting them right makes a real difference to how well you tolerate treatment long-term.
If you haven't yet started treatment and want to check your suitability, check your eligibility with our prescribers, a real clinician reviews every consultation the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.